Xu, Chunliang http://orcid.org/0000-0002-4514-8477
Frenette, Paul S. http://orcid.org/0000-0003-0862-9922
Article History
First Online: 4 April 2019
Competing interests
: P.S.F. has served as consultant for Pfizer, received research funding from Ironwood Pharmaceuticals and owns stock options of Cygnal Therapeutics.